In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Yinggai SongDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-1644-6942 Jochem B BuilDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-4031-0778 Jan ZollDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Marlou Tehupeiory-KooremanDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Hanka VenselaarDepartment of Medical BioSciences, Radboudumc, Nijmegen, the Netherlands.
Ruoyu LiDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Willem J G MelchersDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0002-5446-2230 Paul E VerweijDepartment of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0002-8600-9860 Funding
National Natural Science Foundation of China 82272354
6 · The paper itselfAbstract
The World Health Organization has flagged the rise of drug resistance in
Indexed as
Antifungal AgentsAspergillus fumigatusAzolesCytochrome P-450 Enzyme SystemDrug Resistance, FungalFungal ProteinsPolymorphism, Single NucleotideAspergillosisGenotypeHumansItraconazoleMicrobial Sensitivity TestsMutationPhenotypeVoriconazoleAntifungal AgentsAzolescytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemFungal ProteinsItraconazoleVoriconazoleAspergillus fumigatusazole resistantcyp51Amolecular dockingSNPs
Identifiers
PMID41631961
PMCPMC12959090
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390